14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication

14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication

Bibliographic Details
Main Authors: Mercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, Núria Climent, Elena Mateos, Cristina Rovira, Rafael Duarte, Francisco Cervantes, Montserrat Plana, José M. Miró, José Alcamí, Mayte Coiras
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020307196

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020307196

Similar Items